René Djurup

Director/Board Member at Bioneer A/S

Health Technology

Consumer Services

Profile

René Djurup is currently a Director at Bioneer A.
Previously, he worked as the Head of Research & Development at Novo Nordisk A from 1993 to 1997 and as the Chief Technical Officer at Bavarian Nordic A from 2003 to 2008.
He also held a position as Principal at Copenhagen University Hospital.
Dr. Djurup received a graduate degree from the University of Copenhagen in 1987 and a doctorate degree from the same institution in 1978.

René Djurup active positions

Companies	Position	Start
Bioneer A/S Bioneer A/S Pharmaceuticals: MajorHealth Technology Bioneer A/S develops and manufactures drugs. The firm's products and services drug development, molecular histology, dynamic gastric model, biomarkers and drug targets, protein manufacturing, mammalian cell technology, immune targeting, active ingredients and microorganisms. The company was founded in 2003 and is headquartered in Horsholm, Denmark.	Director/Board Member	-

All active positions of René Djurup

Former positions of René Djurup

Companies	Position	End
BAVARIAN NORDIC A/S	Chief Tech/Sci/R&D Officer	2007-12-31
NOVO NORDISK A/S	Chief Tech/Sci/R&D Officer	1996-12-31
Copenhagen University Hospital	Corporate Officer/Principal	-

See the detail of René Djurup's experience

Training of René Djurup

University of Copenhagen

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of René Djurup's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
NOVO NORDISK A/S	Health Technology
BAVARIAN NORDIC A/S	Health Technology

Private companies	1
Bioneer A/S Bioneer A/S Pharmaceuticals: MajorHealth Technology Bioneer A/S develops and manufactures drugs. The firm's products and services drug development, molecular histology, dynamic gastric model, biomarkers and drug targets, protein manufacturing, mammalian cell technology, immune targeting, active ingredients and microorganisms. The company was founded in 2003 and is headquartered in Horsholm, Denmark.	Health Technology